TriplatinNC and Biomolecules: Building Models Based on Non-covalent Interactions

Area of Science:

• Medicinal Chemistry
• Computational Chemistry
• Biochemistry

Background:

• Polynuclear platinum(II) compounds exhibit potent anticancer activity.
• TriplatinNC (AH78) demonstrates antitumor efficacy comparable to cisplatin.
• Complex charge influences non-covalent interactions with biomolecules like DNA.

Purpose of the Study:

• To provide a benchmark theoretical study of TriplatinNC (AH78).
• To elucidate the non-covalent interactions of TriplatinNC with DNA and heparan sulfate.
• To evaluate these interactions using computational modeling.

Main Methods:

• Utilized small mimetic models to describe non-covalent interactions.
• Employed hybrid QM/MM ONIOM methodology for larger models.
• Investigated interactions with DNA (six base pairs) and heparan sulfate fractions.

Main Results:

• Described non-covalent interactions of TriplatinNC with biomolecular models.
• Evaluated hydrogen bonding between TriplatinNC's amine groups and DNA/heparan sulfate.
• Observed potential for DNA double helix twisting and biomolecular activity inhibition.

Conclusions:

• TriplatinNC's +8 charge facilitates non-covalent interactions with DNA and heparan sulfate.
• Theoretical insights support TriplatinNC's potential as an anticancer agent.
• Further research into these interactions could optimize platinum-based cancer therapies.